Citadel Advisors’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $154M | Buy |
2,652,990
+1,331,777
| +101% | +$61.4M | 0.11% | 573 |
|
|
2025
Q4 | $59.2M | Buy |
1,321,213
+362,115
| +38% | +$15.2M | 0.04% | 1270 |
|
|
2025
Q3 | $38.5M | Buy |
959,098
+839,053
| +699% | +$29.6M | 0.03% | 1637 |
|
|
2025
Q2 | $3.76M | Sell |
120,045
-567,043
| -83% | -$18.5M | ﹤0.01% | 4599 |
|
|
2025
Q1 | $23.1M | Buy |
687,088
+359,785
| +110% | +$13.7M | 0.02% | 1882 |
|
|
2024
Q4 | $12.8M | Sell |
327,303
-395,201
| -55% | -$16.3M | 0.01% | 2659 |
|
|
2024
Q3 | $28.4M | Sell |
722,504
-46,222
| -6% | -$1.86M | 0.03% | 1722 |
|
|
2024
Q2 | $30M | Sell |
768,726
-518,349
| -40% | -$20.7M | 0.03% | 1603 |
|
|
2024
Q1 | $55.4M | Buy |
1,287,075
+20,231
| +2% | +$931K | 0.05% | 1130 |
|
|
2023
Q4 | $58.4M | Buy |
1,266,844
+543,320
| +75% | +$19.2M | 0.06% | 1072 |
|
|
2023
Q3 | $24.7M | Buy |
723,524
+222,512
| +44% | +$8.32M | 0.03% | 1651 |
|
|
2023
Q2 | $19.3M | Sell |
501,012
-370,222
| -42% | -$14.7M | 0.02% | 1928 |
|
|
2023
Q1 | $31.2M | Sell |
871,234
-293,173
| -25% | -$10.8M | 0.03% | 1500 |
|
|
2022
Q4 | $45.9M | Buy |
1,164,407
+22,405
| +2% | +$816K | 0.05% | 1187 |
|
|
2022
Q3 | $41.2M | Sell |
1,142,002
-506,037
| -31% | -$18.2M | 0.05% | 1217 |
|
|
2022
Q2 | $50.1M | Buy |
1,648,039
+206,959
| +14% | +$6.26M | 0.07% | 1019 |
|
|
2022
Q1 | $44.1M | Buy |
1,441,080
+153,277
| +12% | +$4.59M | 0.05% | 1213 |
|
|
2021
Q4 | $40.2M | Buy |
1,287,803
+446,587
| +53% | +$13.3M | 0.04% | 1346 |
|
|
2021
Q3 | $12.9M | Sell |
841,216
-202,327
| -19% | -$3.52M | 0.01% | 2644 |
|
|
2021
Q2 | $19.4M | Buy |
1,043,543
+820,991
| +369% | +$15.1M | 0.02% | 2118 |
|
|
2021
Q1 | $3.98M | Buy |
222,552
+151,002
| +211% | +$2.56M | ﹤0.01% | 4765 |
|
|
2020
Q4 | $1.1M | Sell |
71,550
-240,132
| -77% | -$2.81M | ﹤0.01% | 6603 |
|
|
2020
Q3 | $3.45M | Sell |
311,682
-78,578
| -20% | -$925K | ﹤0.01% | 3733 |
|
|
2020
Q2 | $4.89M | Sell |
390,260
-115,769
| -23% | -$1.47M | 0.01% | 3113 |
|
|
2020
Q1 | $5.74M | Buy |
506,029
+273,764
| +118% | +$3.9M | 0.01% | 2538 |
|
|
2019
Q4 | $3.04M | Sell |
232,265
-39,820
| -15% | -$419K | ﹤0.01% | 3765 |
|
|
2019
Q3 | $2.45M | Sell |
272,085
-165,495
| -38% | -$1.56M | ﹤0.01% | 4158 |
|
|
2019
Q2 | $4.32M | Sell |
437,580
-214,443
| -33% | -$2.05M | 0.01% | 3315 |
|
|
2019
Q1 | $6.63M | Sell |
652,023
-186,279
| -22% | -$1.58M | 0.01% | 2598 |
|
|
2018
Q4 | $5.29M | Buy |
838,302
+84,367
| +11% | +$750K | 0.01% | 2701 |
|
|
2018
Q3 | $9.95M | Buy |
+753,935
| New | +$8.74M | 0.01% | 2104 |
|
Other funds holding XENE
ACA
DCM
PCH
